Complications after BCG vaccination in a big city
https://doi.org/10.21292/2075-1230-2016-94-6-20-24
Abstract
Complications after specific prevention of tuberculosis for the last 10 years have been analyzed using the example of a big city. The frequency of severe complications (BCG-ostitis) made 0.004% and the frequency of minor complications (lymphadenitis) made 0.005% and cold abscesses made 0.01% per 100 000 vaccinated children. Often complications were caused by mistakes in the vaccine administration related to premature discharge from maternity hospital and administration of the vaccine in the polyclinic and also concurrent prenatal disorder. The issue of complications caused by anti-tuberculosis vaccination makes no grounds to review the policy of the primary BCG vaccination.
About the Authors
T. A. Sevostyanova
Moscow Municipal Scientific Practical Center of Tuberculosis Control, Health Department of Moscow
Russian Federation
Russian Federation
Head of DK DO of Diagnostic Center,
10, Stronymka St., Moscow, 107014
V. A. Аksenova
I. M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Research Institute of Phthisiopulmonology by I. M. Sechenov First Moscow State Medical University, Russian Ministry of Health, Doctor of Medical Sciences, Professor, Academician of RANS, Head of Department of Tuberculosis in Children and Adolescents, Chief External Pediatric TB Doctor of the Russian Ministry of Health,
Build. 2, 4, Dostoevsky St., Moscow
E. M. Belilovskiy
Moscow Municipal Scientific Practical Center of Tuberculosis Control, Health Department of Moscow
Russian Federation
Russian Federation
Head of Tuberculosis Epidemiological Monitoring Department,
10, Stronymka St., Moscow, 107014
References
1. Aksenova V.A. Current approaches to the problem of using the anti-tuberculosis vaccine. Epidemiologiya i Vaktsionoprofilaktika, 2004, no. 4, pp. 13-16. (In Russ.)
2. Аksenova V.А., Levi D.T. Tuberkulyoznye vaktsiny. Vaktsiny i vaktsinatsiya. Natsional’noe rukovodstvo. [Tuberculosis vaccines. Vaccines and vaccinations. National guidelines]. 2011, Ch. 18, pp. 371-412.
3. Levi D.T., Аleksandrova N.V., Rukhamina M.L., Podlipaeva I.V. Complication of BCG vaccination Vserossiyskaya nauchno-prakticheskaya konferentsiya Vaktsinologiya 2010. Sovershenstvovanie immunobiologicheskikh sredstv profilaktiki, diagnostiki i lecheniya infektsionnykh bolezney. [All-Russian Scientific Practical Conference on Vaccination 2010. Improvement of immuno-biological means for prevention, diagnostics and treatment of infectious diseases]. Moscow, 2010, pp. 67-68. (In Russ.)
4. Protivotuberkuleznaya rabota v gorode Moskve. Аnaliticheskiy obzor statisticheskikh pokazateley po tuberkulezu, 2013 g. [Tuberculosis control in Moscow. Analytical review of tuberculosis statistical rates, 2013]. Ed. by E.M. Bogorodskaya and V.I. Litvinov, Moscow, MNPTsBT Publ., 2014, pp. 15.
5. Sevostyanova T.А., Аksenova V.А., Levi D.T. Problems of current vaccination against tuberculosis in Russia. Materialy 1-go Kongressa natsionalnoy assotsiatsii ftiziatrov. [Materials of the 1st Congress of the National Phthisiologists’ society]. St. Petersburg, 2012, pp. 197-199. (In Russ.)
6. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2013. Stockholm, European Centre for Disease Prevention and Control, 2013.
7. Raviglione M., Marais B., Floyd K. et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet, 2012, vol. 379, pp. 1902-1913.
8. Veen J., Migliori G. B., Raviglione M. et al. Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur. Respir. J., 2011, vol. 3, pp. 950-959.
9. World Health Organization. BCG (Tuberculosis). www.who.int/biologicals/areas/vaccines/bcg/Tuberculosis/en/Date last accessed: June 7, 2013. Date last updated: June 28, 2012.
Review
For citations:
Sevostyanova T.A., Аksenova V.A., Belilovskiy E.M. Complications after BCG vaccination in a big city. Tuberculosis and Lung Diseases. 2016;94(6):20-24. (In Russ.) https://doi.org/10.21292/2075-1230-2016-94-6-20-24
Views:
2432
Email this article 